Collaborative Advancement of Recovery Excellence
Translating science to service, powered by Gloo
With the lethality, availability and use of stimulants all greatly increasing in the U.S. in recent years and the COVID-19 pandemic complicating the treatment landscape for patients and practitioners alike, it’s critical for providers to weather the storm, Deni Carise, PhD, chief science officer for Recovery Centers of America, told Cocaine, Meth & Stimulant Summit attendees in a Saturday session.
Two-thirds of addiction treatment providers say they have experienced a drop in revenue, and nearly half report an increase in observed staff burnout as a result of the COVID-19 pandemic, according to a recently published NAATP survey.
In a recent survey conducted by the American Psychological Association, 29% of psychologists said they are seeing more patients since the start of the pandemic, and almost all are now using telehealth platforms at least part of the time to provide treatment.
Siobhan Morse, MHSA, CRC, CAI, MAC, divisional director of clinical services in the Behavioral Health Division at UHS, has been presented with the 2020 National Alcohol and Drug Addiction Recovery Month Presidential Proclamation.
Research recently released by the Massachusetts Center for Health Information and Analysis suggests hospitalized patients with a behavioral health comorbidity are at an increased risk for readmission.
Addiction treatment providers who want to improve their quality of care can make strides by focusing in on four specific areas, Siobhan Morse, MHSA, CRC, CAI, MAC, told attendees at a recent webinar presented by the Psychiatry & Behavioral Health Learning Network.
Cognitive behavioral therapy was found to reduce symptoms of insomnia among young adult binge drinkers in a pilot study recently released by the University of Missouri School of Medicine and published in the Sleep Research Society journal.
Early data from Hazelden Betty Ford Foundation suggests that virtual intensive outpatient services have been as effective as on-site IOP treatment, a promising development as providers have moved many operations to virtual platforms as a result of the COVID-19 pandemic.
Universal Health Services and Eleos Health, a behavioral health tech firm, have announced the launch of a six-week pilot program for clinical decision-support software to analyze patient experiences and treatment outcomes in Nashville.
Despite documented efficacy, adoption of medication-assisted treatment among providers remains slow across the U.S., largely because of a fractured treatment system.